dibenzylchlorethamine has been researched along with Sarcoma 180 in 1 studies
Dibenzylchlorethamine: An alpha adrenergic antagonist.
Sarcoma 180: An experimental sarcoma of mice.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deig, EF | 1 |
| Cranford, RE | 1 |
| Riedlinger, DJ | 1 |
| Akers, TG | 1 |
1 other study available for dibenzylchlorethamine and Sarcoma 180
| Article | Year |
|---|---|
Lethal synergy between sarcoma-180/TG cells and vesicular stomatitis virus in mice.
Topics: Animals; Dibenzylchlorethamine; Female; Hypersensitivity; Mice; Neoplasm Transplantation; Sarcoma 18 | 1975 |